Financiële vergelijkingen Takeda Pharmaceutical Company Limited
Aandelen
4502
JP3463000004
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4.151,00 JPY | -0,74% |
|
+0,34% | -0,72% |
10/02 | Alle tarieven en dreigende handelsmaatregelen van Donald Trump | RE |
31/01 | Takeda Pharmaceutical stopt met de ontwikkeling van Soticlestat na mislukte proeven | MT |
Toevoegen aan een lijst 0 geselecteerde | Omzet (N-1) | Nettomarge (N-1) | Ebit-marge (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | |
---|---|---|---|---|---|---|---|
28,19 mld. | 3,38% | 5,02% | 2,1% | 0,36% | 4.66x | ||
34,12 mld. | 15,36% | 20,68% | 48,93% | 9,23% | 2.6x | ||
85,16 mld. | 41,28% | 32,25% | 34,91% | 14,32% | 0.21x | ||
54,32 mld. | 8,95% | 45,64% | 143,18% | 14,46% | 1.82x | ||
66,76 mld. | 13,68% | 34,42% | 43,45% | 15,69% | 0.74x | ||
45,81 mld. | 13,01% | 31,73% | 29,77% | 11,48% | 1.66x | ||
60,12 mld. | 0,61% | 10,33% | 9,18% | 3,56% | 2.77x | ||
50,32 mld. | 23,73% | 38,74% | 34,74% | 15,58% | 0.85x | ||
28,19 mld. | 23,83% | 47,53% | 202,85% | 12,37% | 3.07x | ||
58,5 mld. | 3,62% | 15,9% | 11,37% | 4,96% | 3.8x | ||
47,61 mld. | 12,54% | 29,42% | 13,65% | 4,27% | 0.55x | ||
27,12 mld. | 20,89% | 38,66% | 38,46% | 13,49% | 1.34x | ||
48,3 mld. | 18,53% | 10,77% | 7,93% | 5,22% | 6.98x | ||
7,88 mld. | 29,29% | 39,52% | 21,3% | 23,34% | -1.57x | ||
38,63 mld. | 16,25% | 28,97% | 52,48% | 10,55% | 1.29x | ||
10,59 mld. | 12,53% | 13,21% | 12,8% | 7,95% | -2.01x | ||
14,4 mld. | 9,28% | 22,55% | 6,37% | 3,05% | 3.01x | ||
3,22 mld. | 18,85% | 21,52% | 10,99% | 9,99% | -3.66x | ||
2,25 mld. | 12,37% | 7,87% | - | 2,86% | 26.65x | ||
Gemiddelde | 37,45 mld. | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | 2,88x | |
Gewogen gemiddelde per kap. | 47,29 mld. | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | 2,05x |
- Beurs
- Aandelen
- Koers 4502
- Sector Takeda Pharmaceutical Company Limited
- Financiële vergelijkingen